United States · Funded startup
6 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$73Mraised across 6 rounds since 2011, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $9.0M sold, first sale Dec 2014
No investor was named in the report.
From a historical funding recordSEC filing: $28M sold, first sale Aug 2012
Canaan
Versant Ventures
5AM Ventures
Robin Hood Ventures
BioAdvance
Delaware Crossing InvestorReported by fiercebiotech.com
Reported by finsmes.comSEC filing: $11M sold, first sale Aug 2012
No investor was named in the report.
Reported by sec.govSEC filing: $11M sold, first sale Aug 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Robin Hood VenturesDelaware Crossing InvestorCanaan5AM VenturesBioAdvanceMid Atlantic Angel FundVersant VenturesFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Novira Therapeutics's investors include Robin Hood Ventures, Delaware Crossing Investor, Canaan, 5AM Ventures and BioAdvance, and 2 more on record.
Novira Therapeutics has raised $73M across 6 rounds since 2011.
Novira Therapeutics's most recent round was a Debt of $9.0M in Dec 2014.
Novira Therapeutics's largest round on record is $25M (Series A), in Mar 2013.
Novira Therapeutics's first round on record, in Jul 2011, was backed by Robin Hood Ventures and Delaware Crossing Investor.
Novira Therapeutics's latest named round is a Debt, in Dec 2014.
Novira Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·